Visine
A bottle of Visine® is a brand of eye drops produced by Pfizer Inc.
Visine® Original
The active ingredient in the original Visine® formulation is tetrahydrozoline hydrochloride which is a vasoconstrictor, and therefore constricts the eye's superficial blood vessels to "get the red out", as claimed in Pfizer's advertising.
Administration
As with other eye drops, Visine® is administered topically with 1 to 2 drops applied to the affected eye(s) up to 4 times daily .
Adverse effects
Reducing the blood supply to the eye can prevent, or at least prolong, the healing cycle. Thus, the use of Visine® and other similar products is not helpful in healing the eyes .
Use will create a rebound after a couple of hours and make the eye look even redder. Prolonged use can permanently dilate blood vessels, so use should be limited to 1 or 2 times.
Those using Visine® Original frequently report stinging and burning upon application.
Although the use of Visine® as a poison to induce diarrhoea has been discounted as an urban legend, systemic complications have been reported as a result of poisoning and accidental ingestion.
Clinics & treatments
Medic8® Guides
- Cosmetic Surgery
- Cosmetic Dentistry
- Weight Loss Surgery
- Laser Eye Surgery
- Laser Hair Removal
- Health Insurance
- Life Insurance
- Family Health
- Travel Health
- Medical Tourism
Health centres
- Allergies
- Alternative Health
- Arthritis
- Asthma
- Blood Disorders
- Bones & Joints
- Bowel & Abdominal Problems
- Cancer
- Chest Problems
- Child Health
- Circulation Problems
- Diabetes
- Diet & Nutrition
- Drug Addiction
- Ear, Nose, & Throat Problems
- Elderly Health
- Eye Problems
- Heart Problems
- High Blood Pressure
- Hormone & Endocrine Problems
- Infections
- Infertility
- Liver Problems
- Medications
- Men's Health
- Mental Health
- Nervous System
- Personal & Social Issues
- Pregnancy & Birth
- Preventive Health
- Radiology
- Sexual Health
- Skin Problems
- Sports Medicine
- Surgery
- Travel Health
- Urinary & Kidney Problems
- Vaccination
- Women's Health

